h.bhattacharya
TL2 Moderator · Pune
Contributes reviews on supplier material. Based in Pune.
Joined 21 August 2025 · last posted 1d
79Posts here
1Topics
1Solutions
297Likes received
348Likes given
20Badges
147Days visited
1kPosts read
Most-liked posts
-
Heart failure with preserved ejection fraction: symptom endpoints Replied, post #23 · Clinical › Comorbidities · 15 Jul 2026 · 33 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
Revisiting: Drawing up with one needle and injecting with another Replied, post #62 · Practice › Administration · 6 Apr 2026 · 33 likes post #61 is right about the mechanism and I think understates the practical bit. Injection discomfort: comes from needle gauge (finer = less discomfort), volume…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #6 · Start Here › Welcome · 26 Oct 2025 · 32 likes The moderation log is public. Every staff action is logged with the rule cited and the reasoning stated. If you get moderated, the explanation is there and it is worth…
-
Sodium, potassium and magnesium when intake drops Replied, post #36 · Nutrition & Training › Hydration & electrolytes · 29 Jun 2025 · 31 likes This follows post #33 rather than contradicting it. Constipation and hydration: dehydration makes constipation worse. Increasing fluid intake is the first intervention…
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #24 · Compounds › Secretagogues & GH axis · 13 Mar 2025 · 30 likes CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and persists for days. The version without it does not persist.…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #100 · Practice › Dosing & titration · 28 Apr 2026 · 29 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…
Where this member posts
Badges earned, in order
| Badge | Tier | Granted |
|---|---|---|
| Basic User | bronze | 24 Aug 2025 |
| Welcome | bronze | 25 Aug 2025 |
| Read the Guidelines | bronze | 26 Aug 2025 |
| First Reply | bronze | 28 Aug 2025 |
| First Quote | bronze | 29 Aug 2025 |
| First Link | bronze | 31 Aug 2025 |
| Asked Well | bronze | 2 Sep 2025 |
| First Topic | bronze | 3 Sep 2025 |
| Member | bronze | 21 Sep 2025 |
| First Tag | bronze | 4 Oct 2025 |
| Sourced | bronze | 4 Oct 2025 |
| Reader | bronze | 29 Oct 2025 |
| Generous | bronze | 12 Nov 2025 |
| Editor | bronze | 14 Nov 2025 |
| First Solution | bronze | 5 Dec 2025 |
| Nice Post | bronze | 15 Dec 2025 |
| Good Post | silver | 28 Jan 2026 |
| First Vendor Report | bronze | 10 Feb 2026 |
| Welcoming | silver | 22 May 2026 |
| De-escalator | gold | 27 Jul 2026 |